Allogene retains control of cancer therapy after arbitration ruling
Go back to Allogene retains control of cancer therapy after arbitration ruling| (NASDAQ: ALLO) | Delayed: 1.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.93 | 52 Week High | $ | |||
| Open | $1.93 | 52 Week Low | $ | |||
| Day High | $1.93 | P/E | N/A | |||
| Day Low | $1.93 | EPS | $ | |||
| Volume | 18,198 | |||||
| (NASDAQ: CLLS) | Delayed: 2.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $37.55 | |||
| Open | $2.90 | 52 Week Low | $16.35 | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.90 | EPS | $0.00 | |||
| Volume | 200 | |||||
